Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

But the YoY growth is expected to decline for the Indian Pharmaceutical Market (IPM), projected at approximately 8 per cent, ...

The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.

But sales of Spiriva, approved in chronic obstructive pulmonary disease and asthma, have declined by almost 15% although it is still BI’s biggest drug, generating sales of around 3 billion euros.

The firm stated that the stock is already pricing the one-off benefits of its blockbuster respiratory drug Spiriva in FY25 and FY26. Aside from that, the brokerage also remarked that ...

This reduces the amount of drug deposited on your cheeks ... like Seebri Respimat and Spiriva Respimat. Asthma inhaler differ ...

They are also used as add-on therapy for asthma maintenance in the case of Spiriva. There is also a combination inhaler called Combivent that contains albuterol, a SABA, and the anticholinergic drug ...

The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be ...

For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for ...

The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...

A new breast cancer drug has received quick federal approval after a clinical trial showed it could more than double the time before a common type of breast cancer recurrence worsens.